Inventor · disambiguated record
Söhnke Voss
Also filed as: VOSS SÖHNKE
4 granted patents·8 pending applications·209 citations·filing 2009–2022
82Inventor score
Top patents by PatentIndex Score
12 records- 0197US8968746B2Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulationBAUMHOF PATRICK·Filed 2011·Granted Mar 3, 2015·70 cites·16 claims
- 0294US9572874B2Composition comprising a complexed (M)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereofFOTIN-MLECZEK MARIOLA·Filed 2009·Granted Feb 21, 2017·76 cites·22 claims
- 0394US9226959B2Nucleic acids comprising formula (NuGlXmGnNv)a and derivatives thereof as immunostimulating agent/adjuvantKRAMPS THOMAS·Filed 2009·Granted Jan 5, 2016·57 cites·34 claims
- 0493US11690910B2Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigenCureVac SE·Filed 2019·Granted Jul 4, 2023·6 cites·20 claims
- 0576US2022401555A1NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANTCUREVAC AG·Filed 2022·Application pending·0 cites
- 0675US2023285594A1Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulationCureVac SE·Filed 2022·Application pending·0 cites
- 0764US2021046179A1COMPOSITION COMPRISING A COMPLEXED (m)RNA AND A NAKED mRNA FOR PROVIDING OR ENHANCING AN IMMUNOSTIMULATORY RESPONSE IN A MAMMAL AND USES THEREOFCUREVAC AG·Filed 2020·Application pending·0 cites
- 0863US2020085942A1NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANTCUREVAC AG·Filed 2019·Application pending·0 cites
- 0958US2015118264A1Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigenCUREVAC GMBH·Filed 2013·Application pending·0 cites
- 1056US2015258214A1Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulationCUREVAC GMBH·Filed 2015·Application pending·0 cites
- 1153US2016250321A1NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANTCUREVAC AG·Filed 2015·Application pending·0 cites
- 1251US2017202957A1COMPOSITION COMPRISING A COMPLEXED (m)RNA AND A NAKED mRNA FOR PROVIDING OR ENHANCING AN IMMUNOSTIMULATORY RESPONSE IN A MAMMAL AND USES THEREOFCUREVAC AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Söhnke Voss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →